Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune DiseasesMaysaa Abdulla(Uppsala University), Peter Hollander(Uppsala University)BiomoleculesJanuary 27, 202310.3390/biom13020240Cited by 3SaveCiteExport RISWatch citationsRelated PapersHigh proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome|Blood Advances|2017|50Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma|PLoS ONE|2018|29Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases—A Possible Association with High Rheumatoid Arthritis Disease Activity|Cancers|2022|7Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma|Immunobiology|2019|1